TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
61.70
+1.17 (1.93%)
At close: Dec 20, 2024, 4:00 PM
62.00
+0.30 (0.49%)
After-hours: Dec 20, 2024, 7:55 PM EST
TransMedics Group Market Cap
TransMedics Group has a market cap or net worth of $2.07 billion as of December 20, 2024. Its market cap has decreased by -15.55% in one year.
Market Cap
2.07B
Enterprise Value
2.26B
1-Year Change
-15.55%
Ranking
Category
Stock Price
$61.70
Market Cap Chart
Since May 2, 2019, TransMedics Group's market cap has increased from $452.48M to $2.07B, an increase of 357.64%. That is a compound annual growth rate of 30.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 2.07B | -19.64% |
| Dec 29, 2023 | 2.58B | 30.78% |
| Dec 30, 2022 | 1.97B | 270.34% |
| Dec 31, 2021 | 532.04M | -1.57% |
| Dec 31, 2020 | 540.50M | 34.35% |
| Dec 31, 2019 | 402.32M | -11.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeoGenomics | 2.12B |
| GeneDx Holdings | 2.11B |
| Beam Therapeutics | 2.11B |
| Alignment Healthcare | 2.06B |
| Omnicell | 2.05B |
| LeMaitre Vascular | 2.03B |
| Premier | 2.03B |
| PACS Group | 2.03B |